BEND, Ore., April 30, 2018 -- via NetworkWire -- EVIO Inc. (OTCQB:EVIO) (“EVIO” or “the Company”) a leading provider of cannabis testing and scientific research for the regulated cannabis industry, is pleased to announce that it has executed an asset purchase agreement to acquire 100% of California-based testing lab, Leaf Detective, LLC.
Leaf Detective, Humboldt County’s first licensed cannabis testing facility, is an independently owned and operated testing facility dedicated to providing accurate results in a timely manner. The lab specializes in analytical laboratory testing for medical marijuana dispensaries, cannabis manufacturers, producers and consumers.
Due to California’s July 1 testing deadline mandating licensed retailers to sell only lab tested product, the industry is predicting a shortage of testing services and delays in getting approval to sell the products. This strategic acquisition is part of EVIO’s efforts to further expand into the state to meet increasing demand for analytical testing services.
“Leaf Detective holds one of only 28 licenses issued by the Bureau of Cannabis Control to testing facilities. Upon completion of this acquisition, we will upgrade the facility to meet new testing standards and plan to be operational by end of third quarter,” said William Waldrop, CEO of EVIO Inc. “Our goal is to continue to improve consumer safety and increase shareholder value by capturing additional market share.”
A recent report from industry research firm, BDS Analytics, estimates that California cannabis sales will reach $3.7 billion by the end of 2018 and predicts an increase to $5.1 billion in 2019. Leaf Detective is located in the Emerald Triangle region, the largest cannabis-producing region in the United States, giving EVIO increased exposure to clientele.
Transaction Details
Pursuant to the Agreement, EVIO Inc., will form a new entity, EVIO Labs Humboldt, to purchase 100% of Leaf Detective business assets including equipment, brand, customer lists, customer contracts, rental agreements, and equipment leases for total consideration of US$500,000 in a Convertible Promissory Note, convertible at $1.25 per share.
About EVIO, Inc.
EVIO, Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The Company’s EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation's cannabis supply. EVIO is on track to have 18 of its state-of-the-art testing facilities by year-end 2018.
For more information, visit www.eviolabs.com.
About Leaf Detective, LLC.
Leaf Detective specializes in analytical laboratory testing for medical marijuana dispensaries, cannabis manufacturers, producers and consumers. Our services include cannabinoid profiling, microbial, residual solvent and pesticide testing for flower, trim, and all forms of concentrates including rosin, kief and shatter.
For more information, visit https://leafdetective.com.
CONTACT INFORMATION
Company Contact:
Cheryl Kramp
Director of Marketing
EVIO Inc.
Bend, OR
www.EVIOlabs.com
888.544.EVIO
[email protected]
Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]
Media:
Carrie Booze
North 6th Agency
212-334-9753 ext.142
[email protected]


Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



